{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:56:58Z","timestamp":1794743818714,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7795","license":[{"start":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T00:00:00Z","timestamp":1577232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T00:00:00Z","timestamp":1577232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2020,2,20]]},"DOI":"10.1038\/s41586-019-1911-y","type":"journal-article","created":{"date-parts":[[2019,12,25]],"date-time":"2019-12-25T14:02:41Z","timestamp":1577282561000},"page":"444-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":563,"title":["GDF15 mediates the effects of metformin on body weight and energy balance"],"prefix":"10.1038","volume":"578","author":[{"given":"Anthony P.","family":"Coll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranali","family":"Taskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Rimmington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Tadross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Virtue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Goldspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Miedzybrodzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Konopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Ruiz","family":"Esponda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.-J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. C. Loraine","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rodriguez-Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute A.","family":"Tomaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather P.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Melvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles S. H.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vidal-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Vallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Sreekumaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Gribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard B.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O\u2019Rahilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,25]]},"reference":[{"key":"1911_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393\u2013403 (2002).","journal-title":"N. Engl. J. Med."},{"key":"1911_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","volume":"49","author":"A Ramachandran","year":"2006","unstructured":"Ramachandran, A. et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49, 289\u2013297 (2006).","journal-title":"Diabetologia"},{"key":"1911_CR3","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2337\/db06-0918","volume":"56","author":"JM Lachin","year":"2007","unstructured":"Lachin, J. M. et al. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 56, 1153\u20131159 (2007).","journal-title":"Diabetes"},{"key":"1911_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena, G., Hardie, D. G. & Pearson, E. R. The mechanisms of action of metformin. Diabetologia 60, 1577\u20131585 (2017).","journal-title":"Diabetologia"},{"key":"1911_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.7326\/M18-1605","volume":"170","author":"JW Apolzan","year":"2019","unstructured":"Apolzan, J. W. et al. Long-term weight loss with metformin or lifestyle intervention in the Diabetes Prevention Program Outcomes Study. Ann. Intern. Med. 170, 682\u2013690 (2019).","journal-title":"Ann. Intern. Med."},{"key":"1911_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2337\/dc16-1682","volume":"40","author":"HC Gerstein","year":"2017","unstructured":"Gerstein, H. C. et al. Growth differentiation factor 15 as a novel biomarker for metformin. Diabetes Care 40, 280\u2013283 (2017).","journal-title":"Diabetes Care"},{"key":"1911_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai, V. W. W., Husaini, Y., Sainsbury, A., Brown, D. A. & Breit, S. N. The MIC-1\/GDF15\u2013GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell Metab. 28, 353\u2013368 (2018).","journal-title":"Cell Metab."},{"key":"1911_CR8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican, S. E. et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat. Med. 23, 1150\u20131157 (2017).","journal-title":"Nat. Med."},{"key":"1911_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson, P. J. et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat. Med. 23, 1215\u20131219 (2017).","journal-title":"Nat. Med."},{"key":"1911_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat. Med. 23, 1158\u20131166 (2017).","journal-title":"Nat. Med."},{"key":"1911_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu, J. Y. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259 (2017).","journal-title":"Nature"},{"key":"1911_CR12","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.celrep.2016.04.024","volume":"15","author":"AR Konopka","year":"2016","unstructured":"Konopka, A. R. et al. Hyperglucagonemia mitigates the effect of metformin on glucose production in prediabetes. Cell Rep. 15, 1394\u20131400 (2016).","journal-title":"Cell Rep."},{"key":"1911_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","volume":"2","author":"D Preiss","year":"2014","unstructured":"Preiss, D. et al. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2, 116\u2013124 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1911_CR14","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/dom.13264","volume":"20","author":"LJ McCreight","year":"2018","unstructured":"McCreight, L. J. et al. Pharmacokinetics of metformin in patients with gastrointestinal intolerance. Diabetes Obes. Metab. 20, 1593\u20131601 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"1911_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1464-5491.2007.02068.x","volume":"24","author":"NG Forouhi","year":"2007","unstructured":"Forouhi, N. G., Luan, J., Hennings, S. & Wareham, N. J. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet. Med. 24, 200\u2013207 (2007).","journal-title":"Diabet. Med."},{"key":"1911_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.201607110","volume":"216","author":"HK Chung","year":"2017","unstructured":"Chung, H. K. et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J. Cell Biol. 216, 149\u2013165 (2017).","journal-title":"J. Cell Biol."},{"key":"1911_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbrc.2017.08.096","volume":"498","author":"D Li","year":"2018","unstructured":"Li, D., Zhang, H. & Zhong, Y. Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice. Biochem. Biophys. Res. Commun. 498, 388\u2013394 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1911_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","volume":"29","author":"S Patel","year":"2019","unstructured":"Patel, S. et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 29, 707\u2013718 (2019).","journal-title":"Cell Metab."},{"key":"1911_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1172\/JCI30558","volume":"117","author":"Y Shu","year":"2007","unstructured":"Shu, Y. et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Invest. 117, 1422\u20131431 (2007).","journal-title":"J. Clin. Invest."},{"key":"1911_CR20","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00125-016-3992-6","volume":"59","author":"RA DeFronzo","year":"2016","unstructured":"DeFronzo, R. A. et al. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. Diabetologia 59, 1645\u20131654 (2016).","journal-title":"Diabetologia"},{"key":"1911_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/dom.12826","volume":"19","author":"D Preiss","year":"2017","unstructured":"Preiss, D. et al. Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes. Diabetes Obes. Metab. 19, 356\u2013363 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"1911_CR22","doi-asserted-by":"publisher","first-page":"93936","DOI":"10.1172\/jci.insight.93936","volume":"3","author":"E Bahne","year":"2018","unstructured":"Bahne, E. et al. Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight 3, 93936 (2018).","journal-title":"JCI Insight"},{"key":"1911_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","volume":"54","author":"A Maida","year":"2011","unstructured":"Maida, A., Lamont, B. J., Cao, X. & Drucker, D. J. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice. Diabetologia 54, 339\u2013349 (2011).","journal-title":"Diabetologia"},{"key":"1911_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J de la Cuesta-Zuluaga","year":"2017","unstructured":"de la Cuesta-Zuluaga, J. et al. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care 40, 54\u201362 (2017).","journal-title":"Diabetes Care"},{"key":"1911_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"Shin, N. R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727\u2013735 (2014).","journal-title":"Gut"},{"key":"1911_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262\u2013266 (2015).","journal-title":"Nature"},{"key":"1911_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz, M., Guigas, B. & Viollet, B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat. Rev. Endocrinol. 15, 569\u2013589 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1911_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2967\/jnumed.112.106666","volume":"54","author":"M Massollo","year":"2013","unstructured":"Massollo, M. et al. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J. Nucl. Med. 54, 259\u2013266 (2013).","journal-title":"J. Nucl. Med."},{"key":"1911_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-1531","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse, J. B. et al. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 39, 198\u2013205 (2016).","journal-title":"Diabetes Care"},{"key":"1911_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10163","volume":"474","author":"WC Skarnes","year":"2011","unstructured":"Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337\u2013342 (2011).","journal-title":"Nature"},{"key":"1911_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00335-012-9422-2","volume":"23","author":"A Bradley","year":"2012","unstructured":"Bradley, A. et al. The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm. Genome 23, 580\u2013586 (2012).","journal-title":"Mamm. Genome"},{"key":"1911_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nmeth.1342","volume":"6","author":"SJ Pettitt","year":"2009","unstructured":"Pettitt, S. J. et al. Agouti C57BL\/6N embryonic stem cells for mouse genetic resources. Nat. Methods 6, 493\u2013495 (2009).","journal-title":"Nat. Methods"},{"key":"1911_CR33","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s00125-012-2686-y","volume":"55","author":"AD McNeilly","year":"2012","unstructured":"McNeilly, A. D., Williamson, R., Balfour, D. J., Stewart, C. A. & Sutherland, C. A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia 55, 3061\u20133070 (2012).","journal-title":"Diabetologia"},{"key":"1911_CR34","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.4049\/jimmunol.170.8.3977","volume":"170","author":"CF Ortega-Cava","year":"2003","unstructured":"Ortega-Cava, C. F. et al. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170, 3977\u20133985 (2003).","journal-title":"J. Immunol."},{"key":"1911_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.molmet.2017.11.005","volume":"7","author":"DA Goldspink","year":"2018","unstructured":"Goldspink, D. A. et al. Mechanistic insights into the detection of free fatty and bile acids by ileal glucagon-like peptide-1 secreting cells. Mol. Metab. 7, 90\u2013101 (2018).","journal-title":"Mol. Metab."},{"key":"1911_CR36","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"1911_CR37","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI43122","volume":"120","author":"ST Rashid","year":"2010","unstructured":"Rashid, S. T. et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 120, 3127\u20133136 (2010).","journal-title":"J. Clin. Invest."},{"key":"1911_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature10424","volume":"478","author":"K Yusa","year":"2011","unstructured":"Yusa, K. et al. Targeted gene correction of \u03b11-antitrypsin deficiency in induced pluripotent stem cells. Nature 478, 391\u2013394 (2011).","journal-title":"Nature"},{"key":"1911_CR39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nmeth.1593","volume":"8","author":"G Chen","year":"2011","unstructured":"Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424\u2013429 (2011).","journal-title":"Nat. Methods"},{"key":"1911_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nprot.2012.153","volume":"8","author":"NR Hannan","year":"2013","unstructured":"Hannan, N. R., Segeritz, C. P., Touboul, T. & Vallier, L. Production of hepatocyte-like cells from human pluripotent stem cells. Nat. Protoc. 8, 430\u2013437 (2013).","journal-title":"Nat. Protoc."}],"updated-by":[{"DOI":"10.1038\/s41586-020-2031-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1911-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1911-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1911-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:01:33Z","timestamp":1684605693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1911-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,25]]},"references-count":40,"journal-issue":{"issue":"7795","published-print":{"date-parts":[[2020,2,20]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1911-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/677831","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.737127674.793570321","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.737127674.793572984","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.737127674.793571815","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,25]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-020-2031-4","URL":"https:\/\/doi.org\/10.1038\/s41586-020-2031-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.W. has received grant support from Roche Diagnostics, AstraZeneca and Boehringer Ingelheim. N.S. has consulted for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Napp, Novo Nordisk and Sanofi, and received grant support from Boehringer Ingelheim. M.C., P.T. and B.B.A. are or were employees of NGM Biopharmaceuticals and may hold NGM stock or stock options. F.R. and F.M.G. have received support from AstraZeneca and Eli Lilly. F.M.G. has provided remunerated consultancy services to Kallyope. S.O. has provided remunerated consultancy services to Pfizer, AstraZeneca, Novo-Nordisk and ERX Pharmaceuticals. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}